Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on September 8, 2026

an hour ago

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

an hour ago

MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Indeterminate GlobeNewswire

an hour ago

Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring® Implant and Delivery System Procedures

Indeterminate GlobeNewswire

an hour ago

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

an hour ago

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

an hour ago

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

Indeterminate GlobeNewswire

an hour ago

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

an hour ago

AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group

Indeterminate GlobeNewswire

an hour ago

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire

an hour ago

Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET

Indeterminate GlobeNewswire

an hour ago

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

an hour ago

Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure

Indeterminate GlobeNewswire

an hour ago

MIMEDX to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

an hour ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

an hour ago

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

an hour ago

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Indeterminate GlobeNewswire

an hour ago

R1 Makes Fast Company’s Eighth Annual List of the Best Workplaces for Innovators in Biotech, Healthcare and Life Sciences

Indeterminate GlobeNewswire

an hour ago

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

an hour ago

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

Indeterminate GlobeNewswire

2 hours ago

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire